<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p93" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_93{left:130px;bottom:1195px;letter-spacing:0.2px;}
#t2_93{left:804px;bottom:1195px;letter-spacing:0.13px;}
#t3_93{left:128px;bottom:1104px;letter-spacing:0.16px;}
#t4_93{left:238px;bottom:1104px;letter-spacing:-0.16px;}
#t5_93{left:141px;bottom:1070px;letter-spacing:-0.01px;}
#t6_93{left:248px;bottom:1070px;letter-spacing:-0.01px;}
#t7_93{left:143px;bottom:1014px;letter-spacing:-0.29px;}
#t8_93{left:250px;bottom:1034px;letter-spacing:-0.01px;}
#t9_93{left:250px;bottom:1014px;letter-spacing:-0.01px;}
#ta_93{left:248px;bottom:959px;letter-spacing:-0.04px;}
#tb_93{left:238px;bottom:899px;letter-spacing:-0.01px;}
#tc_93{left:238px;bottom:880px;letter-spacing:-0.01px;}
#td_93{left:238px;bottom:860px;letter-spacing:-0.01px;}
#te_93{left:238px;bottom:806px;letter-spacing:-0.01px;}
#tf_93{left:238px;bottom:772px;letter-spacing:-0.01px;}
#tg_93{left:238px;bottom:752px;letter-spacing:-0.01px;}
#th_93{left:385px;bottom:752px;letter-spacing:-0.01px;}
#ti_93{left:238px;bottom:733px;letter-spacing:-0.01px;}
#tj_93{left:238px;bottom:713px;letter-spacing:-0.01px;}
#tk_93{left:238px;bottom:659px;letter-spacing:-0.01px;}
#tl_93{left:238px;bottom:640px;letter-spacing:-0.01px;}
#tm_93{left:238px;bottom:620px;letter-spacing:-0.01px;}
#tn_93{left:238px;bottom:601px;letter-spacing:-0.01px;}
#to_93{left:238px;bottom:547px;letter-spacing:-0.01px;}
#tp_93{left:238px;bottom:527px;letter-spacing:-0.01px;}
#tq_93{left:238px;bottom:508px;letter-spacing:-0.01px;}
#tr_93{left:238px;bottom:488px;letter-spacing:-0.01px;}
#ts_93{left:238px;bottom:469px;letter-spacing:-0.01px;}
#tt_93{left:238px;bottom:450px;letter-spacing:-0.01px;}
#tu_93{left:238px;bottom:430px;letter-spacing:-0.01px;}
#tv_93{left:238px;bottom:411px;letter-spacing:-0.01px;}
#tw_93{left:238px;bottom:391px;letter-spacing:-0.01px;}
#tx_93{left:238px;bottom:372px;letter-spacing:-0.01px;}
#ty_93{left:238px;bottom:352px;letter-spacing:-0.01px;}
#tz_93{left:238px;bottom:220px;letter-spacing:-0.01px;}
#t10_93{left:238px;bottom:201px;letter-spacing:-0.01px;}
#t11_93{left:238px;bottom:182px;letter-spacing:-0.01px;}
#t12_93{left:238px;bottom:162px;letter-spacing:-0.01px;}
#t13_93{left:238px;bottom:143px;letter-spacing:-0.01px;}
#t14_93{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_93{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_93{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_93{font-size:21px;font-family:NotoSans-Regular_7j-;color:#000;}
.s3_93{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
.s4_93{font-size:28px;font-family:NotoSans-Regular_7j-;color:#000;}
.s5_93{font-size:10px;font-family:NotoSans-Regular_7j-;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts93" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg93Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg93" style="-webkit-user-select: none;"><object width="908" height="1286" data="93/93.svg" type="image/svg+xml" id="pdf93" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_93" class="t s0_93">7.8. Functionality and quality of life </span><span id="t2_93" class="t s1_93">93 </span>
<span id="t3_93" class="t s2_93">7.8. </span><span id="t4_93" class="t s2_93">Functionality and quality of life </span>
<span id="t5_93" class="t s3_93">7.60. </span><span id="t6_93" class="t s3_93">Consensus-based statement </span>
<span id="t7_93" class="t s4_93">EEC </span>
<span id="t8_93" class="t s3_93">Differences in voice quality after TLM (transoral laser microsurgery) and primary </span>
<span id="t9_93" class="t s3_93">radiotherapy of T2 glottic cancer cannot be evaluated due to a lack of studies. </span>
<span id="ta_93" class="t s5_93">Strong consensus: 100% </span>
<span id="tb_93" class="t s3_93">The functionality and quality of life of early laryngeal carcinoma depends largely on the quality </span>
<span id="tc_93" class="t s3_93">of the voice. The additional relevant aspects of dysphagia, aspiration and respiratory </span>
<span id="td_93" class="t s3_93">impairment in advanced tumors are not present here [6]. </span>
<span id="te_93" class="t s3_93">Functionality/voice quality </span>
<span id="tf_93" class="t s3_93">The quality of the voice after partial resection of the larynx depends on how much tissue was </span>
<span id="tg_93" class="t s3_93">resected in the area of </span><span id="th_93" class="t s3_93">the vocal folds, but also on whether other areas of the larynx can </span>
<span id="ti_93" class="t s3_93">function as a replacement glottis postoperatively. The quality of the voice can therefore vary </span>
<span id="tj_93" class="t s3_93">considerably between patients despite similar surgical procedures. </span>
<span id="tk_93" class="t s3_93">The voice quality of patients after transoral laser surgery is analyzed in the literature using both </span>
<span id="tl_93" class="t s3_93">subjective patient-based instruments and objective examiner-based methods. The use of </span>
<span id="tm_93" class="t s3_93">different measurement instruments in different studies makes it difficult to compare the results </span>
<span id="tn_93" class="t s3_93">[6]. </span>
<span id="to_93" class="t s3_93">There is a prospective randomized controlled study from Finland on voice quality after </span>
<span id="tp_93" class="t s3_93">transoral laser surgery and radiotherapy for T1aN0M0 vocal cord carcinomas [338]. The study </span>
<span id="tq_93" class="t s3_93">analyzed the voice quality of 56 patients who were randomized to two groups: transoral laser </span>
<span id="tr_93" class="t s3_93">surgery and radiotherapy of 66Gy in daily fractions of 2 Gy over 6.5 weeks. Voice quality was </span>
<span id="ts_93" class="t s3_93">assessed using the GRBAS scale (Grade, Roughness, Breathiness, Asthenia, Strain), </span>
<span id="tt_93" class="t s3_93">videostroboscopy, and patient self-assessment at baseline and 6 and 24 months after </span>
<span id="tu_93" class="t s3_93">treatment. Voice quality after therapy was assessed similarly in both groups, but patients after </span>
<span id="tv_93" class="t s3_93">transoral laser therapy had a more breathy voice and more frequently had incomplete vocal </span>
<span id="tw_93" class="t s3_93">cord closure. Patients who received radiotherapy also reported less discomfort in daily life due </span>
<span id="tx_93" class="t s3_93">to hoarseness after 24 months. The authors conclude that primary radiotherapy may be the </span>
<span id="ty_93" class="t s3_93">treatment of choice for patients with high demands on good voice quality. </span>
<span id="tz_93" class="t s3_93">Three systematic reviews of retrospective analyses examined voice quality after transoral </span>
<span id="t10_93" class="t s3_93">laser therapy versus radiotherapy of T1 and T2 vocal cord carcinomas. Spielmann et al. [339] </span>
<span id="t11_93" class="t s3_93">analyzed results from 15 observational studies on voice quality after therapy of T1 and T2 </span>
<span id="t12_93" class="t s3_93">vocal cord carcinomas in a systematic review. In twelve studies, no significant difference in </span>
<span id="t13_93" class="t s3_93">voice quality was found, three of the included studies reported </span>
<span id="t14_93" class="t s0_93">Â© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
